You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study

Citation Tools

Article menu

Download PDFPDF

XML
Oncology
Original research
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Dane F, Ozgurdal K, Yalçın Ş, et al
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study
BMJ Open 2020;10:e027665. doi: 10.1136/bmjopen-2018-027665